These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives. Young CW; Raymond V Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251 [No Abstract] [Full Text] [Related]
8. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer. Boven E; Schlüper HM; Erkelens CA; Pinedo HM Eur J Cancer; 1990; 26(9):983-6. PubMed ID: 2149026 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study. Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433 [No Abstract] [Full Text] [Related]
11. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung. Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403 [No Abstract] [Full Text] [Related]
12. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial. Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053 [No Abstract] [Full Text] [Related]
13. The biochemical pharmacology of nogalamycin and its derivatives. Li LH; Krueger WC Pharmacol Ther; 1991; 51(2):239-55. PubMed ID: 1838416 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group. Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809 [No Abstract] [Full Text] [Related]
15. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial. Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875 [No Abstract] [Full Text] [Related]
16. Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study. Vance RB; Crowley JJ; Macdonald JS; Ahmann FR Invest New Drugs; 1991 Feb; 9(1):73-5. PubMed ID: 1851143 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice. Sternberg CN; Sordillo PP; Cheng E; Chuang YJ; Niedzwiecki D Am J Clin Oncol; 1987 Jun; 10(3):219-21. PubMed ID: 2884864 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of menogaril in advanced colorectal cancer. Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of menogaril in patients with metastatic sarcomas and no prior chemotherapy exposure. Buckner JC; Edmonson JH; Ingle JN; Schaid DJ Am J Clin Oncol; 1989 Oct; 12(5):384-6. PubMed ID: 2529759 [TBL] [Abstract][Full Text] [Related]
20. Menogaril in the treatment of malignant mesothelioma: a phase II study. Hudis CA; Kelsen DP Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]